Home / Healthcare / Medical Device / U.S. Hemostats Market
U.S. Hemostats Market Size, Share & COVID-19 Impact Analysis, By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others), By End User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Country Forecast, 2023-2030
Report Format: PDF | Published Date: Jan, 2024 | Report ID: FBI108837. | Status : PublishedSummary
TOC
Methodology
Market Segmentation
Frequently Asked Questions
How much is the U.S. hemostats market worth?
Fortune Business Insights says that the U.S. market was worth USD 1.45 billion in 2022.
At what CAGR is the U.S. hemostats market projected to grow during the forecast period of 2023-2030?
The market is expected to exhibit a CAGR of 7.2% during the forecast period of 2023-2030.
Which is the leading segment in the market by application?
By application, the general surgery segment accounted for a leading share of the market.
Who are the top players in the market?
Johnson & Johnson Services, Inc. (MENTOR), BD, and Baxter are the top players in the market.
- Global
- 2022
- 2019-2021
- 70